Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Tumori|January 6, 2022
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trialBenedetta Conte, Filippo Montemurro, Alessia Levaggi, et al.
Clinical Breast Cancer|March 21, 2024
The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA TrialVeronique Debien, Elisa Agostinetto, Marco Bruzzone, et al.
Current Treatment Options in Oncology|March 13, 2024
Ovarian Suppression: Early Menopause and Late EffectsChiara Molinelli, Flavia Jacobs, Guilherme Nader-Marta, et al.
British Journal of Cancer|April 2, 2020
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 studyEva Blondeaux, Matteo Lambertini, Andrea Michelotti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 13, 2024
The journey of patients affected by metastatic hormone receptor-positive/HER2-negative breast cancer from CDK 4/6 inhibitors to second-line treatment: A real-world analysis of 701 patients enrolled in the GIM14/BIOMETA studyChiara Molinelli, Marco Bruzzone, Eva Blondeaux, et al.
Tumori|October 15, 2024
Practices and views about palliative care at the end of life: A survey of oncologists from the Italian region of LiguriaIrene Giannubilo, Linda Battistuzzi, Tommaso Ruelle, et al.
Clinical Breast Cancer|November 19, 2019
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational StudyBenedetta Conte, Alessandra Fabi, Francesca Poggio, et al.
Critical Reviews in Oncology/Hematology|August 10, 2023
Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumabVeronique Debien, Guilherme Nader Marta, Elisa Agostinetto, et al.
BMC Palliative Care|May 22, 2024
Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancerIrene Giannubilo, Linda Battistuzzi, Eva Blondeaux, et al.
Breast (Edinburgh, Scotland)|June 27, 2026
Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trialChiara Molinelli, Virginia Delucchi, Eva Blondeaux, et al.
Pageof 3